260 related articles for article (PubMed ID: 11359396)
1. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
Stockfleth E; Meyer T; Benninghoff B; Christophers E
Br J Dermatol; 2001 May; 144(5):1050-3. PubMed ID: 11359396
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases.
Ulrich C; Busch JO; Meyer T; Nindl I; Schmook T; Sterry W; Stockfleth E
Br J Dermatol; 2006 Aug; 155(2):451-4. PubMed ID: 16882188
[TBL] [Abstract][Full Text] [Related]
3. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients.
Ulrich C; Bichel J; Euvrard S; Guidi B; Proby CM; van de Kerkhof PC; Amerio P; Rønnevig J; Slade HB; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2(Suppl 2):25-31. PubMed ID: 18067628
[TBL] [Abstract][Full Text] [Related]
4. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
[TBL] [Abstract][Full Text] [Related]
5. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
Stockfleth E; Sterry W; Carey-Yard M; Bichel J
Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
[TBL] [Abstract][Full Text] [Related]
6. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials.
Korman N; Moy R; Ling M; Matheson R; Smith S; McKane S; Lee JH
Arch Dermatol; 2005 Apr; 141(4):467-73. PubMed ID: 15837864
[TBL] [Abstract][Full Text] [Related]
7. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
[TBL] [Abstract][Full Text] [Related]
8. [Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
Oster-Schmidt C; Altmeyer P; Markus S
J Dtsch Dermatol Ges; 2003 Oct; 1(10):790-6. PubMed ID: 16281815
[TBL] [Abstract][Full Text] [Related]
9. Gene expression in actinic keratoses: pharmacological modulation by imiquimod.
Lysa B; Tartler U; Wolf R; Arenberger P; Benninghoff B; Ruzicka T; Hengge UR; Walz M
Br J Dermatol; 2004 Dec; 151(6):1150-9. PubMed ID: 15606509
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
Gupta AK; Davey V; Mcphail H
J Cutan Med Surg; 2005 Oct; 9(5):209-14. PubMed ID: 16502198
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream.
Lee PK; Harwell WB; Loven KH; Phillips TJ; Whiting DA; Andres KL; Lee JH
Dermatol Surg; 2005 Jun; 31(6):659-64. PubMed ID: 15996416
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp.
Tanghetti E; Werschler P
J Drugs Dermatol; 2007 Feb; 6(2):144-7. PubMed ID: 17373172
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.
Harrison LI; Skinner SL; Marbury TC; Owens ML; Kurup S; McKane S; Greene RJ
Arch Dermatol Res; 2004 Jun; 296(1):6-11. PubMed ID: 15083310
[TBL] [Abstract][Full Text] [Related]
14. Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod.
Torres A; Storey L; Anders M; Miller RL; Bulbulian BJ; Jin J; Raghavan S; Lee J; Slade HB; Birmachu W
Br J Dermatol; 2007 Dec; 157(6):1132-47. PubMed ID: 17944981
[TBL] [Abstract][Full Text] [Related]
15. Treatment of multiple, multiform actinic keratoses on the head with imiquimod 5% cream.
Stockfleth E; Ulrich C; Lange-Asschenfeldt B; Kremer HJ; Drecoll U; Maus J; Röwert-Huber J
Eur J Dermatol; 2009; 19(4):355-9. PubMed ID: 19467962
[TBL] [Abstract][Full Text] [Related]
16. Topical imiquimod to treat intraepidermal carcinoma.
Hengge UR; Stark R
Arch Dermatol; 2001 Jun; 137(6):709-11. PubMed ID: 11405756
[No Abstract] [Full Text] [Related]
17. Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.
Papadavid E; Stratigos AJ; Falagas ME
Expert Opin Pharmacother; 2007 Aug; 8(11):1743-55. PubMed ID: 17685890
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.
Stockfleth E; Meyer T; Benninghoff B; Salasche S; Papadopoulos L; Ulrich C; Christophers E
Arch Dermatol; 2002 Nov; 138(11):1498-502. PubMed ID: 12437457
[TBL] [Abstract][Full Text] [Related]
19. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.
Gebauer K; Shumack S; Cowen PS
Br J Dermatol; 2009 Oct; 161(4):897-903. PubMed ID: 19545297
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of imiquimod as an adjunct to cryotherapy for actinic keratoses.
Tan JK; Thomas DR; Poulin Y; Maddin F; Tang J
J Cutan Med Surg; 2007; 11(6):195-201. PubMed ID: 18042331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
